ProShares Ultra Nasdaq Biotechnology
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.95
資產淨值: 83.97
成立日期: 06/04/2010
 
分析
市值分佈:
53.76%
大市值
6.31%
中市值
2.60%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 248  
0%
 
100%
     10大 (31.38%)
代號 名稱 佔比% 持有日期
KODKodiak Sciences0.0727/02/2026
ZBIOZenas Biopharma Inc.0.0727/02/2026
IMCRImmunocore Holdings plc0.0727/02/2026
RAPPRapport Therapeutics Inc.0.0727/02/2026
CRVSCorvus Pharmaceuticals0.0727/02/2026
PGENPrecigen0.0727/02/2026
ATAIAtaiBeckley Inc0.0727/02/2026
COLLCollegium Pharmaceutical0.0727/02/2026
ORICOric Pharmaceuticals0.0727/02/2026
SEPNSepterna Inc0.0727/02/2026
TSHATaysha Gene Therapies0.0627/02/2026
SVRASavara0.0627/02/2026
GLUEMonte Rosa Therapeutics0.0627/02/2026
SANASana Biotechnology0.0627/02/2026
PAHCPhibro Animal Health Corp0.0627/02/2026
GRFSGrifols SA0.0627/02/2026
DAWNDay One Biopharmaceuticals0.0527/02/2026
ABCLAbCellera Biologics0.0527/02/2026
INBXInhibrx Biosciences Inc.0.0527/02/2026
GERNGeron Corp0.0527/02/2026
  1    2    3    4    5    6   7    8    9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.